Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation

Giulia Grande, Valentina Cucumo, Ilaria Cova, Roberta Ghiretti, Laura Maggiore, Eleonora Lacorte, Daniela Galimberti, Elio Scarpini, Francesca Clerici, Simone Pomati, Nicola Vanacore, Claudio Mariani

Research output: Contribution to journalArticle

Abstract

The prognostic value of mild cognitive impairment (MCI) is being questioned, with some MCI subjects reverting to normal cognition (NC). The reversion rate varies mostly depending on the study design, the setting, and both MCI and NC definitions. Previous studies have focused on the profile of subjects who revert to NC, but the role of comorbidities has not been entirely investigated. We aimed to evaluate the proportion of MCI subjects who revert to NC in a memory clinic context, focusing on the role of comorbidities. Between 2004 and 2013, 374 MCI subjects were recruited. During a mean time of 32 ± 25.5 months, 21 subjects (5.6) reverted to NC. Subjects who reverted to NC were younger (p = 0.0001), more educated (p = 0.0001), had a better global cognition (p = 0.0001), as assessed by the Mini-Mental State Examination (MMSE) and suffered from more comorbidities (p = 0.002), as assessed by Cumulative Illness Rating Scale (CIRS) than those who developed dementia. The Cox Regression Model, constructed to adjust for the confounders, showed that the higher were the MMSE (HR = 1.83, CI 95: 1.07-3.11) and the CIRS score (HR = 1.3, CI 95 0.88-1.92) at baseline, the higher was the probability of returning to NC than developing dementia, though the last association was not significant. Subjects who reverted to NC were more frequently affected by respiratory (p = 0.002), urologic (p = 0.012), and psychiatric (p = 0.012) diseases. The cognitive performance of subjects with medical comorbidities could benefit from preventive strategies aimed at treating the underlying diseases.

Original languageEnglish
Pages (from-to)57-67
Number of pages11
JournalJournal of Alzheimer's Disease
Volume51
Issue number1
DOIs
Publication statusPublished - Feb 27 2016

Fingerprint

Cognition
Comorbidity
Dementia
Cognitive Dysfunction
Proportional Hazards Models
Psychiatry

Keywords

  • Comorbidity
  • dementia
  • mild cognitive impairment
  • prevention

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Grande, G., Cucumo, V., Cova, I., Ghiretti, R., Maggiore, L., Lacorte, E., ... Mariani, C. (2016). Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation. Journal of Alzheimer's Disease, 51(1), 57-67. https://doi.org/10.3233/JAD-150786

Reversible Mild Cognitive Impairment : The Role of Comorbidities at Baseline Evaluation. / Grande, Giulia; Cucumo, Valentina; Cova, Ilaria; Ghiretti, Roberta; Maggiore, Laura; Lacorte, Eleonora; Galimberti, Daniela; Scarpini, Elio; Clerici, Francesca; Pomati, Simone; Vanacore, Nicola; Mariani, Claudio.

In: Journal of Alzheimer's Disease, Vol. 51, No. 1, 27.02.2016, p. 57-67.

Research output: Contribution to journalArticle

Grande, G, Cucumo, V, Cova, I, Ghiretti, R, Maggiore, L, Lacorte, E, Galimberti, D, Scarpini, E, Clerici, F, Pomati, S, Vanacore, N & Mariani, C 2016, 'Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation', Journal of Alzheimer's Disease, vol. 51, no. 1, pp. 57-67. https://doi.org/10.3233/JAD-150786
Grande, Giulia ; Cucumo, Valentina ; Cova, Ilaria ; Ghiretti, Roberta ; Maggiore, Laura ; Lacorte, Eleonora ; Galimberti, Daniela ; Scarpini, Elio ; Clerici, Francesca ; Pomati, Simone ; Vanacore, Nicola ; Mariani, Claudio. / Reversible Mild Cognitive Impairment : The Role of Comorbidities at Baseline Evaluation. In: Journal of Alzheimer's Disease. 2016 ; Vol. 51, No. 1. pp. 57-67.
@article{7f45b027067f41cfaf92feb22a564451,
title = "Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation",
abstract = "The prognostic value of mild cognitive impairment (MCI) is being questioned, with some MCI subjects reverting to normal cognition (NC). The reversion rate varies mostly depending on the study design, the setting, and both MCI and NC definitions. Previous studies have focused on the profile of subjects who revert to NC, but the role of comorbidities has not been entirely investigated. We aimed to evaluate the proportion of MCI subjects who revert to NC in a memory clinic context, focusing on the role of comorbidities. Between 2004 and 2013, 374 MCI subjects were recruited. During a mean time of 32 ± 25.5 months, 21 subjects (5.6) reverted to NC. Subjects who reverted to NC were younger (p = 0.0001), more educated (p = 0.0001), had a better global cognition (p = 0.0001), as assessed by the Mini-Mental State Examination (MMSE) and suffered from more comorbidities (p = 0.002), as assessed by Cumulative Illness Rating Scale (CIRS) than those who developed dementia. The Cox Regression Model, constructed to adjust for the confounders, showed that the higher were the MMSE (HR = 1.83, CI 95: 1.07-3.11) and the CIRS score (HR = 1.3, CI 95 0.88-1.92) at baseline, the higher was the probability of returning to NC than developing dementia, though the last association was not significant. Subjects who reverted to NC were more frequently affected by respiratory (p = 0.002), urologic (p = 0.012), and psychiatric (p = 0.012) diseases. The cognitive performance of subjects with medical comorbidities could benefit from preventive strategies aimed at treating the underlying diseases.",
keywords = "Comorbidity, dementia, mild cognitive impairment, prevention",
author = "Giulia Grande and Valentina Cucumo and Ilaria Cova and Roberta Ghiretti and Laura Maggiore and Eleonora Lacorte and Daniela Galimberti and Elio Scarpini and Francesca Clerici and Simone Pomati and Nicola Vanacore and Claudio Mariani",
year = "2016",
month = "2",
day = "27",
doi = "10.3233/JAD-150786",
language = "English",
volume = "51",
pages = "57--67",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Reversible Mild Cognitive Impairment

T2 - The Role of Comorbidities at Baseline Evaluation

AU - Grande, Giulia

AU - Cucumo, Valentina

AU - Cova, Ilaria

AU - Ghiretti, Roberta

AU - Maggiore, Laura

AU - Lacorte, Eleonora

AU - Galimberti, Daniela

AU - Scarpini, Elio

AU - Clerici, Francesca

AU - Pomati, Simone

AU - Vanacore, Nicola

AU - Mariani, Claudio

PY - 2016/2/27

Y1 - 2016/2/27

N2 - The prognostic value of mild cognitive impairment (MCI) is being questioned, with some MCI subjects reverting to normal cognition (NC). The reversion rate varies mostly depending on the study design, the setting, and both MCI and NC definitions. Previous studies have focused on the profile of subjects who revert to NC, but the role of comorbidities has not been entirely investigated. We aimed to evaluate the proportion of MCI subjects who revert to NC in a memory clinic context, focusing on the role of comorbidities. Between 2004 and 2013, 374 MCI subjects were recruited. During a mean time of 32 ± 25.5 months, 21 subjects (5.6) reverted to NC. Subjects who reverted to NC were younger (p = 0.0001), more educated (p = 0.0001), had a better global cognition (p = 0.0001), as assessed by the Mini-Mental State Examination (MMSE) and suffered from more comorbidities (p = 0.002), as assessed by Cumulative Illness Rating Scale (CIRS) than those who developed dementia. The Cox Regression Model, constructed to adjust for the confounders, showed that the higher were the MMSE (HR = 1.83, CI 95: 1.07-3.11) and the CIRS score (HR = 1.3, CI 95 0.88-1.92) at baseline, the higher was the probability of returning to NC than developing dementia, though the last association was not significant. Subjects who reverted to NC were more frequently affected by respiratory (p = 0.002), urologic (p = 0.012), and psychiatric (p = 0.012) diseases. The cognitive performance of subjects with medical comorbidities could benefit from preventive strategies aimed at treating the underlying diseases.

AB - The prognostic value of mild cognitive impairment (MCI) is being questioned, with some MCI subjects reverting to normal cognition (NC). The reversion rate varies mostly depending on the study design, the setting, and both MCI and NC definitions. Previous studies have focused on the profile of subjects who revert to NC, but the role of comorbidities has not been entirely investigated. We aimed to evaluate the proportion of MCI subjects who revert to NC in a memory clinic context, focusing on the role of comorbidities. Between 2004 and 2013, 374 MCI subjects were recruited. During a mean time of 32 ± 25.5 months, 21 subjects (5.6) reverted to NC. Subjects who reverted to NC were younger (p = 0.0001), more educated (p = 0.0001), had a better global cognition (p = 0.0001), as assessed by the Mini-Mental State Examination (MMSE) and suffered from more comorbidities (p = 0.002), as assessed by Cumulative Illness Rating Scale (CIRS) than those who developed dementia. The Cox Regression Model, constructed to adjust for the confounders, showed that the higher were the MMSE (HR = 1.83, CI 95: 1.07-3.11) and the CIRS score (HR = 1.3, CI 95 0.88-1.92) at baseline, the higher was the probability of returning to NC than developing dementia, though the last association was not significant. Subjects who reverted to NC were more frequently affected by respiratory (p = 0.002), urologic (p = 0.012), and psychiatric (p = 0.012) diseases. The cognitive performance of subjects with medical comorbidities could benefit from preventive strategies aimed at treating the underlying diseases.

KW - Comorbidity

KW - dementia

KW - mild cognitive impairment

KW - prevention

UR - http://www.scopus.com/inward/record.url?scp=84960119469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960119469&partnerID=8YFLogxK

U2 - 10.3233/JAD-150786

DO - 10.3233/JAD-150786

M3 - Article

AN - SCOPUS:84960119469

VL - 51

SP - 57

EP - 67

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -